# Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia

> **NCT03514446** · PHASE4 · UNKNOWN · sponsor: **Thomas Benfield** · enrollment: 284 (estimated)

## Conditions studied

- Staphylococcus Aureus Bacteremia

## Interventions

- **DRUG:** Antibiotic therapy duration for 7 days

## Key facts

- **NCT ID:** NCT03514446
- **Lead sponsor:** Thomas Benfield
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 284 (ESTIMATED)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03514446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03514446, "Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03514446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*